Bristol-Myers Squibb (BMY)
$60.64 0.13 (0.21%)
16:02 EDT BMY Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 99.12B
PE Ratio 106.39
Volume (Avg. Vol.) 6.60M
Day's Range 60.53 - 61.27
52-Week Range 45.76 - 68.34
Dividend & Yield 1.60 (2.64%)
BMY Stock Predictions, Articles, and Bristol-Myers Squibb News
- From InvestorPlace
- From the Web
MyoKardia's major, $13.1 billon deal with fellow pharmaceutical company Bristol Myers Squibb sent MYOK stock soaring on Monday.
Bristol-Myers Squibb, Uber, Facebook, Micron and Twilio were our top stock trades for Friday. That said, let's look at the charts now.
Bristol-Myers Squibb earnings on Thursday have BMY stock rising higher after the company beat EPS and revenue estimates from Wall Street.
Thanks to its Celgene acquisition, Bristol-Myers Squibb looks attractive ahead of earnings. Here's why you should buy BMY stock.
Ahead earnings, Bristol-Myers Squibb is a great value play. In fact, BMY stock is worth 30%-70% more than its current share price.
These 5 healthcare stocks look like the sector's best, with downside protection and room for price appreciation even if the market falters.
BMY stock looks cheap here. Bristol-Myers is a defensive value with an attractive yield, cheap valuation, and plenty of potential upside.
Value stocks have been out of favor for some time — but that will change at some point. When it does, these 10 names should be winners.
These five healthcare stocks have low P/E ratios and ample yields, making them cheap and profitable options for investors.
Friday's big stock charts feature pharmaceutical-market names that recently posted terrific earnings data.
Tuesday's big stock charts feature health-care-sector names that may offer value and leadership.
Amazon, Dick's Sporting Goods, American Airlines, United Airlines and Bristol-Myers Squibb were our top stock trades for Wednesday.
Amarin stock has been on fire in 2019, but the reaction to its latest news was discouraging. Is that a buying opportunity or a warning sign?
Options trading was hot in Bristol-Myers Squibb, Cronos and Canopy Growth stock on Tuesday. Here’s what the data suggests moving forward.
Goldman Sachs analysts came out with three conviction buys on Monday. Here's what else happened in the stock market today.
Options trading was buzzing in Bristol-Myers Squibb, Shopify and Walmart stock on Wednesday. Here are the metrics that matter moving forward.
Roku, Bristol-Myers Squibb, Bank of America and Gogo were our top stock trades for Tuesday. Here's a look at the charts.
From Talk Markets
Navellier RatingsPowered by Portfolio Grader